Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-May-19 8:58 PM View:  | Mamet Julien CHIEF SCIENTIFIC OFFICER Director | HepaLife Technologies Inc. (ALQA) | 03-May-19 | Grant | 240,454 | -- | -- | 100% 0 to 240.45K | |
| 07-May-19 9:10 PM View: | Abel Stan E Director | HepaLife Technologies Inc. (ALQA) | 03-May-19 | Grant | 54,117 | -- | -- | 100% 0 to 54.12K | |
| 07-May-19 9:02 PM View: | Podlesak Dennis Director | HepaLife Technologies Inc. (ALQA) | 03-May-19 | Grant | 85,254 | -- | -- | 100% 0 to 85.25K | |
| 07-May-19 8:51 PM View: | Orr Rick CHIEF EXECUTIVE OFFICER Director | HepaLife Technologies Inc. (ALQA) | 03-May-19 | Grant | 142,090 | -- | -- | 100% 0 to 142.09K | |
| 07-May-19 9:06 PM View: | Weber Eckard Director | HepaLife Technologies Inc. (ALQA) | 03-May-19 | Grant Duplicate | 85,254 | -- | -- | 100% 0 to 85.25K | |
| 25-Sep-17 4:11 PM View: | Pionati Pellegrino See Remarks | HepaLife Technologies Inc. (ALQA) | 21-Sep-17 | Payment of Exercise | 69,978 | $0.42 | $29,390.80 | (12%) 576.58K to 506.6K | |
| 25-Sep-17 4:41 PM View: | Barton Bradford Chief Operating Officer | HepaLife Technologies Inc. (ALQA) | 21-Sep-17 | Payment of Exercise | 67,536 | $0.42 | $28,365.10 | (11%) 626.36K to 558.82K | |
| 25-Sep-17 4:20 PM View: | Posner Brian M Chief Financial Officer | HepaLife Technologies Inc. (ALQA) | 21-Sep-17 | Payment of Exercise | 70,833 | $0.42 | $29,749.90 | (13%) 547.25K to 476.42K | |
| 29-Jun-17 12:54 PM View: | Johnson David Ian President and CEO Director | HepaLife Technologies Inc. (ALQA) | 28-Jun-17 | Grant | 300,000 | -- | -- | 18% 1.69M to 1.99M | |
| 28-Jun-17 5:13 PM View: | Pionati Pellegrino See Remarks | HepaLife Technologies Inc. (ALQA) | 28-Jun-17 | Grant | 100,000 | -- | -- | 21% 476.58K to 576.58K | |
| 28-Jun-17 4:31 PM View: | Barton Bradford Chief Operating Officer | HepaLife Technologies Inc. (ALQA) | 28-Jun-17 | Grant | 100,000 | -- | -- | 19% 526.36K to 626.36K | |
| 28-Jun-17 4:30 PM View: | Posner Brian M Chief Financial Officer | HepaLife Technologies Inc. (ALQA) | 28-Jun-17 | Grant | 100,000 | -- | -- | 22% 447.25K to 547.25K | |
| 26-Jun-17 10:05 AM View: | Zeldis Jerome B Director | HepaLife Technologies Inc. (ALQA) | 23-Jun-17 | Acquisition (other) | 100,000 | -- | -- | 15% 686.75K to 786.75K | |
| 26-Jun-17 10:55 AM View: | Pionati Pellegrino See Remarks | HepaLife Technologies Inc. (ALQA) | 23-Jun-17 | Grant | 205,715 | -- | -- | 76% 270.86K to 476.58K | |
| 26-Jun-17 10:54 AM View: | Barton Bradford Chief Operating Officer | HepaLife Technologies Inc. (ALQA) | 23-Jun-17 | Grant | 205,715 | -- | -- | 64% 320.64K to 526.36K | |
| 26-Jun-17 10:56 AM View: | Posner Brian M Chief Financial Officer | HepaLife Technologies Inc. (ALQA) | 23-Jun-17 | Grant | 205,715 | -- | -- | 85% 241.54K to 447.25K | |
| 26-Jun-17 5:01 PM View: | Johnson David Ian President and CEO Director | HepaLife Technologies Inc. (ALQA) | 23-Jun-17 | Grant | 500,000 | -- | -- | 42% 1.19M to 1.69M | |
| 21-Jun-17 5:30 PM View: | Pionati Pellegrino See Remarks | HepaLife Technologies Inc. (ALQA) | 15-Jun-17 | Payment of Exercise | 10,032 | $0.37 | $3,711.84 | (4%) 280.9K to 270.86K | |
| 13-Apr-17 4:07 PM View: | Celgene Corp /de/ 10% Owner | HepaLife Technologies Inc. (ALQA) | 11-Apr-17 | Acquisition (other) | 296,277 | -- | -- | 4% 7.05M to 7.34M | |
| 04-Apr-17 9:05 AM View: | Wagner Mark T Director | HepaLife Technologies Inc. (ALQA) | 03-Apr-17 | Private Purchase | 62,500 | $0.40 | $25,000.00 | 19% 331.8K to 394.3K | |
| 04-Apr-17 9:00 AM View: | Johnson David Ian President and CEO Director | HepaLife Technologies Inc. (ALQA) | 03-Apr-17 | Private Purchase | 250,000 | $0.40 | $100,000.00 | 26% 944.54K to 1.19M | |
| 04-Apr-17 9:02 AM View: | Leone Joseph M Director | HepaLife Technologies Inc. (ALQA) | 03-Apr-17 | Private Purchase | 25,000 | $0.40 | $10,000.00 | 133% 18.82K to 43.82K | |
| 04-Apr-17 9:02 AM View: | Pionati Pellegrino See Remarks | HepaLife Technologies Inc. (ALQA) | 03-Apr-17 | Private Purchase | 50,000 | $0.40 | $20,000.00 | 22% 230.9K to 280.9K | |
| 04-Apr-17 9:04 AM View: | Barton Bradford Chief Operating Officer | HepaLife Technologies Inc. (ALQA) | 03-Apr-17 | Private Purchase | 75,000 | $0.40 | $30,000.00 | 31% 245.64K to 320.64K | |
| 04-Apr-17 9:05 AM View: | Wagner Mark T Director | HepaLife Technologies Inc. (ALQA) | 21-Mar-17 | Acquisition (other) | 75,876 | $0.67 | $50,836.90 | 30% 255.93K to 331.8K | |
| 01-Mar-17 4:19 PM View: | Celgene Corp /de/ 10% Owner | HepaLife Technologies Inc. (ALQA) | 27-Feb-17 | Market Purchase | 4,000,000 | $0.50 | $2,000,000.00 | 131% 3.05M to 7.05M | |
| 01-Mar-17 6:04 AM View: | Zeldis Jerome B Director | HepaLife Technologies Inc. (ALQA) | 27-Feb-17 | Market Purchase | 400,000 | $0.50 | $200,000.00 | 139% 286.75K to 686.75K | |
| 13-May-16 3:01 PM View: | Barton Bradford Chief Operating Officer | HepaLife Technologies Inc. (ALQA) | 11-May-16 | Grant | 100,000 | -- | -- | 69% 145.64K to 245.64K | |
| 13-May-16 2:58 PM View: | Posner Brian M Chief Financial Officer | HepaLife Technologies Inc. (ALQA) | 11-May-16 | Grant | 100,000 | -- | -- | 71% 141.54K to 241.54K | |
| 13-May-16 3:04 PM View: | Johnson David Ian President and CEO Director | HepaLife Technologies Inc. (ALQA) | 11-May-16 | Grant | 300,000 | -- | -- | 47% 644.53K to 944.53K | |
| 13-May-16 3:00 PM View: | Pionati Pellegrino See Remarks | HepaLife Technologies Inc. (ALQA) | 11-May-16 | Grant | 100,000 | -- | -- | 76% 130.9K to 230.9K | |
| 20-May-16 3:29 PM View: | Wagner Mark T Director | HepaLife Technologies Inc. (ALQA) | 16-Mar-16 | Acquisition (other) | 73,893 | $2.61 | $192,861.00 | 42% 174.03K to 247.93K | |
| 11-Feb-16 4:24 PM View: | Johnson David Ian President and CEO Director | HepaLife Technologies Inc. (ALQA) | 09-Feb-16 | Grant | 59,932 | -- | -- | 10% 584.6K to 644.53K | |
| 11-Feb-16 4:24 PM View: | Pionati Pellegrino See Remarks | HepaLife Technologies Inc. (ALQA) | 09-Feb-16 | Grant | 14,384 | -- | -- | 12% 116.51K to 130.9K | |
| 11-Feb-16 4:24 PM View: | Barton Bradford Chief Operating Officer | HepaLife Technologies Inc. (ALQA) | 09-Feb-16 | Grant | 24,658 | -- | -- | 20% 120.98K to 145.64K | |
| 11-Feb-16 4:24 PM View: | Posner Brian M Chief Financial Officer | HepaLife Technologies Inc. (ALQA) | 09-Feb-16 | Grant | 24,658 | -- | -- | 21% 116.88K to 141.54K | |
| 10-Nov-15 10:53 AM View: | Posner Brian M Chief Financial Officer | HepaLife Technologies Inc. (ALQA) | 09-Nov-15 | Market Purchase | 5,000 | $3.04 | $15,200.00 | 4% 111.88K to 116.88K | |
| 09-Nov-15 12:04 PM View: | Johnson David Ian President and CEO Director | HepaLife Technologies Inc. (ALQA) | 06-Nov-15 | Market Purchase | 8,650 | $2.92 | $25,258.00 | 2% 575.95K to 584.6K | |
| 09-Nov-15 12:00 PM View: | Leone Joseph M Director | HepaLife Technologies Inc. (ALQA) | 06-Nov-15 | Market Purchase | 3,500 | $2.78 | $9,730.00 | 23% 15.32K to 18.82K | |
| 12-Nov-15 8:41 AM View: | Sklar Jeffrey Director | HepaLife Technologies Inc. (ALQA) | 06-Nov-15 | Market Purchase | 1,500 | $2.95 | $4,425.00 | 6% 23.54K to 25.04K | |
| 09-Nov-15 11:50 AM View: | Pionati Pellegrino Chief Strategy & Marketing Off | HepaLife Technologies Inc. (ALQA) | 06-Nov-15 | Market Purchase | 10,000 | $2.95 | $29,500.00 | 9% 106.51K to 116.51K | |
| 09-Nov-15 3:08 PM View: | Barton Bradford Chief Operating Officer | HepaLife Technologies Inc. (ALQA) | 06-Nov-15 | Market Purchase | 5,000 | $2.97 | $14,850.00 | 4% 115.98K to 120.98K | |
| 09-Nov-15 11:58 AM View: | Wagner Mark T Director | HepaLife Technologies Inc. (ALQA) | 06-Nov-15 | Market Purchase | 8,000 | $2.88 | $23,040.00 | 5% 174.03K to 182.03K | |
| 09-Nov-15 11:55 AM View: | Zeldis Jerome B Director | HepaLife Technologies Inc. (ALQA) | 06-Nov-15 | Market Purchase | 14,000 | $2.91 | $40,740.00 | 5% 272.75K to 286.75K | |
| 10-Aug-15 11:47 AM View: | Posner Brian M Chief Financial Officer | HepaLife Technologies Inc. (ALQA) | 10-Aug-15 | Market Purchase | 2,500 | $5.02 | $12,550.00 | 2% 109.38K to 111.88K | (63%) |
| 06-Jul-15 4:15 PM View: | Johnson David Ian President and CEO Director | HepaLife Technologies Inc. (ALQA) | 01-Jul-15 | Payment of Exercise | 19,191 | $5.35 | $102,672.00 | (3%) 595.14K to 575.95K | |
| 17-Jun-15 4:06 PM View: | Pionati Pellegrino See Remarks | HepaLife Technologies Inc. (ALQA) | 15-Jun-15 | Grant | 120,000 | -- | -- | 100% 0 to 120.0K | |
| 17-Jun-15 4:06 PM View: | Pionati Pellegrino See Remarks | HepaLife Technologies Inc. (ALQA) | 15-Jun-15 | Payment of Exercise | 13,488 | $5.25 | $70,812.00 | (11%) 120.0K to 106.51K | 64% |
| 10-Jun-15 10:00 AM View: | Barton Bradford Chief Operating Officer | HepaLife Technologies Inc. (ALQA) | 08-Jun-15 | Market Purchase | 3,000 | $5.24 | $15,735.00 | 3% 112.98K to 115.98K | (64%) |
| 02-Jun-15 3:09 PM View: | Wagner Mark T Director | HepaLife Technologies Inc. (ALQA) | 29-May-15 | Grant | 174,033 | -- | -- | 100% 0 to 174.03K |
